Caricamento...

N348I in HIV-1 Reverse Transcriptase Decreases Susceptibility to Tenofovir and Etravirine in Combination with Other Resistance Mutations

We previously demonstrated that N348I in HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance. However, both of these inhibitors are currently infrequently used in developed countries and the impact of N348I on newer RT inhibitors, such as tenofovir and etravirine, is unknown. In...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Sluis-Cremer, Nicolas, Moore, Katie, Radzio, Jessica, Sonza, Secondo, Tachedjian, Gilda
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2010
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2874243/
https://ncbi.nlm.nih.gov/pubmed/20010074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0b013e3283315697
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !